Related Experiment Videos
Locally administered ocular corticosteroids: benefits and risks.
Charles N J McGhee1, Simon Dean, Helen Danesh-Meyer
1Discipline of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. c.mcghee@auckland.ac.nz
Drug Safety
|February 1, 2002
Summary
Ocular corticosteroids effectively treat inflammation but pose risks like glaucoma and cataracts. Optimizing delivery methods is crucial to balance benefits and minimize adverse effects for better eye health.
Area of Science:
- Ophthalmology
- Pharmacology
- Drug Delivery Systems
Background:
- Corticosteroids are potent treatments for ocular inflammation.
- Adverse ocular and systemic events are significant concerns.
- Optimized drug delivery aims to enhance efficacy and reduce side effects.
Purpose of the Study:
- To review the therapeutic benefits of locally administered ocular corticosteroids.
- To assess the risks and adverse effects associated with their use.
- To explore advancements in ophthalmic corticosteroid delivery.
Main Methods:
- Review of existing literature on ocular corticosteroid preparations and delivery techniques.
- Analysis of factors influencing intraocular drug penetration.
- Evaluation of reported adverse effects and their mechanisms.
Main Results:
- Topical drops and ointments are primary administration methods, with significant variability in intraocular concentration.
- Periocular injections have a limited role; intraocular devices are under development.
- Risks include corticosteroid-induced ocular hypertension, glaucoma, cataracts, and other ocular morbidities.
Conclusions:
- Careful use of ocular corticosteroids is essential to maximize therapeutic benefits while mitigating risks.
- Further research into targeted delivery systems is needed.
- Monitoring for adverse effects is critical for patient safety.